RE: Biosafety of sorting revisited

From: Alice L. Givan <Alice.L.Givan@dartmouth.edu>
Date: Mon Apr 19 2004 - 08:41:19 EST
Hello,
I am also just now going through these issues about the biosafety with regard to sorting
-- in preparation for the purchase and siting of a new sorter in our facility.	When I
suggested to my users that human samples for sorting should all be tested in advance for
Hep and HIV, they, essentially,  said that this would not be advisable/possible for the
following reasons.
1) Timing would be difficult
2) It would be expensive
3) It would bring up ethical issues
4) Negative tests for a few specific pathogens would not rule out recent exposure of the
donor to those pathogens and/or positivity to all the other untested pathogens.

I have absolutely no sympathy for the first three excuses.  But,  the fourth excuse does
have some validity.  If we realize that negative results for a few pathogens does not
really mean that a sample is safe,  then we must treat all samples with high precaution. 
And,  if we need to treat all samples with high precaution,  then it can be argued that
there is no real point in testing (and it could lead to false security).

What are your thoughts?

Alice

Alice L. Givan, Director
Englert Cell Analysis Laboratory
of the Norris Cotton Cancer Center
Dartmouth Medical School
Lebanon, NH 03756 USA
tel 603-650-7661
fax 603-6540-6130
givan@dartmouth.edu
www.dartmouth.edu/~celllab
Received on Mon Apr 19 12:58:00 2004

This archive was generated by hypermail 2.1.8 : Wed Apr 21 2004 - 03:12:02 EST